The increased body weight, liver weight, and hepatomegaly in WD-induced mice were accompanied by simultaneous elevation of basic diagnostic serum markers, indicating the presence of NAFLD and metabolic syndromes, such as serum AST, ALT, TC, TG, LDL, and glucose levels. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.